Variants in USP48 encoding ubiquitin hydrolase are associated with autosomal dominant non-syndromic hereditary hearing loss.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
15 09 2021
Historique:
received: 29 04 2021
revised: 25 05 2021
accepted: 25 05 2021
pubmed: 2 6 2021
medline: 8 4 2022
entrez: 1 6 2021
Statut: ppublish

Résumé

Non-Syndromic Hereditary Hearing Loss (NSHHL) is a genetically heterogeneous sensory disorder with about 120 genes already associated. Through exome sequencing (ES) and data aggregation, we identified a family with six affected individuals and one unrelated NSHHL patient with predicted-to-be deleterious missense variants in USP48. We also uncovered an eighth patient presenting unilateral cochlear nerve aplasia and a de novo splice variant in the same gene. USP48 encodes a ubiquitin carboxyl-terminal hydrolase under evolutionary constraint. Pathogenicity of the variants is supported by in vitro assays that showed that the mutated proteins are unable to hydrolyze tetra-ubiquitin. Correspondingly, three-dimensional representation of the protein containing the familial missense variant is situated in a loop that might influence the binding to ubiquitin. Consistent with a contribution of USP48 to auditory function, immunohistology showed that the encoded protein is expressed in the developing human inner ear, specifically in the spiral ganglion neurons, outer sulcus, interdental cells of the spiral limbus, stria vascularis, Reissner's membrane and in the transient Kolliker's organ that is essential for auditory development. Engineered zebrafish knocked-down for usp48, the USP48 ortholog, presented with a delayed development of primary motor neurons, less developed statoacoustic neurons innervating the ears, decreased swimming velocity and circling swimming behavior indicative of vestibular dysfunction and hearing impairment. Corroboratingly, acoustic startle response assays revealed a significant decrease of auditory response of zebrafish lacking usp48 at 600 and 800 Hz wavelengths. In conclusion, we describe a novel autosomal dominant NSHHL gene through a multipronged approach combining ES, animal modeling, immunohistology and molecular assays.

Identifiants

pubmed: 34059922
pii: 6290104
doi: 10.1093/hmg/ddab145
doi:

Substances chimiques

Ubiquitin 0
Hydrolases EC 3.-
USP48 protein, human EC 3.4.19.12
Ubiquitin-Specific Proteases EC 3.4.19.12

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1785-1796

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Sissy Bassani (S)

Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.

Edward van Beelen (E)

Department of Otorhinolaryngology, Leiden University Medical Center, Leiden, The Netherlands.

Mireille Rossel (M)

MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.

Norine Voisin (N)

Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.

Anna Morgan (A)

Institute for Maternal and Child Health, IRCCS, Burlo Garofolo, Trieste, Italy.

Yoan Arribat (Y)

Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.

Nicolas Chatron (N)

Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
Service de Génétique, Hospices Civils de Lyon, Lyon, France.

Jacqueline Chrast (J)

Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.

Massimiliano Cocca (M)

Institute for Maternal and Child Health, IRCCS, Burlo Garofolo, Trieste, Italy.

Benjamin Delprat (B)

MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.

Flavio Faletra (F)

Institute for Maternal and Child Health, IRCCS, Burlo Garofolo, Trieste, Italy.

Giuliana Giannuzzi (G)

Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.

Nicolas Guex (N)

Bioinformatics Competence Center, University of Lausanne, Lausanne, Switzerland.

Roxane Machavoine (R)

Centre de référence Surdités Génétiques, Hôpital Necker, Institut Imagine, Paris, France.

Sylvain Pradervand (S)

Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.

Jeroen J Smits (JJ)

Hearing and Genes, Department of Otorhinolaryngology and Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Jiddeke M van de Kamp (JM)

Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Alban Ziegler (A)

Centre de référence Surdités Génétiques, Hôpital Necker, Institut Imagine, Paris, France.

Francesca Amati (F)

Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.

Sandrine Marlin (S)

Centre de référence Surdités Génétiques, Hôpital Necker, Institut Imagine, Paris, France.

Hannie Kremer (H)

Hearing and Genes, Department of Otorhinolaryngology and Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Heiko Locher (H)

Department of Otorhinolaryngology, Leiden University Medical Center, Leiden, The Netherlands.

Tangui Maurice (T)

MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.

Paolo Gasparini (P)

Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Institute for Maternal and Child Health, IRCCS, Burlo Garofolo, Trieste, Italy.

Giorgia Girotto (G)

Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Institute for Maternal and Child Health, IRCCS, Burlo Garofolo, Trieste, Italy.

Alexandre Reymond (A)

Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH